Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Rhode Island Business Daily.
Press releases published on September 2, 2025
NN, Inc. Executive Management to Present at the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference
CHARLOTTE, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that Chris Bohnert, Senior Vice President and …
CarGurus to Present at the 2025 Goldman Sachs Communacopia + Technology Conference
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jason Trevisan, Chief Executive Officer, is scheduled to …
SL Green Announces Acquisition of 346 Madison Avenue
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced that it has entered into a contract to purchase 346 Madison Avenue and the adjacent site at 11 East 44th Street, for $160.0 …
Kura Sushi USA to Participate in Two Investor Conferences in September
IRVINE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that it will participate in the following investor conferences: On …
Zscaler Reports Fourth Quarter and Fiscal 2025 Financial Results
Fourth Quarter Highlights Revenue grows 21% year-over-year to $719.2 million Annual Recurring Revenue ("ARR") grows 22% year-over-year to $3,015 million Calculated billings grows 32% year-over-year to $1,202.3 million Deferred revenue grows 30% year-over- …
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Rackspace Technology Names Gajen Kandiah Chief Executive Officer
SAN ANTONIO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a global provider of hybrid cloud and AI solutions, today announced that its Board of Directors has appointed Gajen Kandiah as Chief Executive Officer, effective September …
XPLR Infrastructure, LP fka NextEra Energy Partners, LP Investors: Please contact the Portnoy Law Firm to recover your losses. September 8, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises XPLR Infrastructure, LP fka NextEra Energy Partners, LP ("XPLR Infrastructure" or the " …
Katapult to Participate in H.C. Wainwright 27th Annual Global Investment Conference
PLANO, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce focused financial technology company, announced that Orlando Zayas, CEO, and Nancy Walsh, CFO, will participate in the H.C. …
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees an …
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial …
HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results
Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25. Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income of $94.6 million, …
Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
COPENHAGEN, Denmark, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR 2025, the annual meeting of the American Society for Bone …
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)
PURCHASE, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, closed its previously announced registered …